首页|基于网络药理学及实验探究益癸方汤防治绝经后骨质疏松症的作用及机制

基于网络药理学及实验探究益癸方汤防治绝经后骨质疏松症的作用及机制

扫码查看
目的 结合网络药理学及实验探究益癸方汤防治绝经后骨质疏松症的作用及机制.方法 通过中药系统药理学数据库与分析平台等数据库搜索方剂中主要成分及靶点,利用GeneCard、Drugbank筛选疾病靶点,再使用Cytoscape 3.7.1进行药物-疾病靶点网格的构建,最后进行基因本体论及京都基因与基因组百科全书分析.采用随机数字表法将25只大鼠分为假手术组、模型组、益癸方汤组、戊酸雌二醇组、益癸方汤+戊酸雌二醇组,每组5只.除假手术组以外,其余组采用去卵巢手术法造模.术后1个月开始给药,益癸方汤组给予10mL/(kg·d)益癸方汤灌胃,戊酸雌二醇组给予0.21 mg/(kg·d)戊酸雌二醇灌胃,益癸方汤+戊酸雌二醇组给予益癸方汤10 mL/(kg·d)+戊酸雌二醇0.21 mg/(kg·d)灌胃,模型组及假手术组给予10 mL/(kg·d)蒸馏水灌胃.给药12周后,注射2%戊巴比妥钠麻醉后取主动脉血,颈椎脱臼法处死大鼠后取左右股骨组织.采用微型计算机断层扫描分析大鼠股骨骨微细结构,包括骨体积分数(BV/TV)、骨小梁厚度(Tb.Th)、骨小梁数量、骨小梁间隔;采用ELISA法检测血清I型前胶原N端前肽(PINP)、抗酒石酸酸性磷酸酶5b、雌二醇(E2)、卵泡刺激素(FSH)水平;采用Western blot法检测大鼠股骨组织中信号传导和转录激活因子3(STAT3)、Janus激酶(JAK)、蛋白激酶B(Akt)蛋白表达.结果 结合网络药理学分析益癸方汤中可能含有槲皮素、木犀草素、丹参酮、柚皮素、谷甾醇等活性成分.核心靶点包括丝裂原活化蛋白激酶(MAPK)3、Akt1、TNF等,涉及MAPK、磷脂酰肌醇3激酶(PI3K)/Akt等信号通路.动物实验结果显示,与模型组比较,益癸方汤组、戊酸雌二醇组、益癸方汤+戊酸雌二醇组大鼠股骨组织BV/TV、Tb.Th升高,血清中PINP、E2水平升高,FSH水平降低,STAT3、JAK、Akt蛋白表达水平降低,差异均有统计学意义(均P<0.05).结论 益癸方汤可能通过下调PI3K/Akt、JAK/STAT信号通路调控炎症、细胞凋亡等防治绝经后骨质疏松症.
Efficacy and mechanisms of Chinese herbal medicine Yiguifang Decoction in prevention and treatment of postmenopausal osteoporosis:a network pharmacology and experimental study
Objective To investigate the efficacy and mechanisms of Chinese herbal medicine Yiguifang Decoction in prevention and treatment of postmenopausal osteoporosis.Methods In network pharmacology study,the main components and targets in the prescriptions were searched through Traditional Chinese Medicine System Pharmacology Database and Analysis Platform;the disease targets were selected from GeneCard and DrugBank.Subsequently,Cytoscape 3.7.1 was employed to construct the drug-disease target network,followed by gene ontology and Kyoto encyclopedia of genes and genomes pathway analysis.In experimental study,25 rats were divided into sham operation group,model group,Yiguifang group,estradiol group and Yiguifang+estradiol group with 5 rats in each group.Except the sham operation group,the ovariectomy was performed to establish the menopause model in last 4 groups.One month after surgery,intragastric administrations of 10 mL/(kg·d)Yiguifang Decoction,0.21 mg/(kg·d)estradiol valerate,and 10 mL/(kg·d)Yiguifang Decoction+0.21 mg/(kg·d)estradiol valerate were given to Yiguifang group,estradiol group,and Yiguifang+Estradiol group,respectively;while 10 mL/(kg·d)distilled water was given to model group and sham operation group.After 12 weeks of administration,the rats were euthanized using 2%pentobarbital sodium injection,aortic blood and the femoral bone samples were obtained.Micro-computed tomography was employed to analyze the femoral bone microstructure,including bone volume/tissue volume(BV/TV),trabecular thickness(Tb.Th),trabecular number(Tb.N),and trabecular separation(Tb.Sp).ELISA was used to measure the serum levels of procollagen type I N-terminal propeptide(PINP),tartrateresistant acid phosphatase 5b(TRACP-5b),estradiol,and follicle-stimulating hormone(FSH).Western blot analysis was conducted to evaluate the protein expression of signal transducer and activator of transcription 3(STAT3),Janus kinase(JAK),and protein kinase B(Akt)in rat femoral bone tissues.Results Network pharmacology analysis revealed that Yiguifang Decoction contained active ingredients such as quercetin,luteolin,tanshinone,naringenin,and sitosterol;and core targets included mitogen-activated protein kinase(MAPK)3,Akt1,TNF,involving signaling pathways such as MAPK and phosphatidylinositol 3-kinase(PI3K)/Akt.Animal experiments showed that compared to the model group,rats treated with Yiguifang Decoction,estradiol,and Yiguifang Decoction+estradiol exhibited increased bone microstructure parameters BV/TV,Tb.Th.Serum levels of PINP and estradiol were elevated,while FSH levels were reduced.Protein expression levels of STAT3,JAK,and Akt were decreased(all P<0.05).Conclusion Chinese herbal medicine Yiguifang Decoction may prevent postmenopausal osteoporosis by downregulating the PI3K/Akt and JAK/STAT signaling pathways to regulate inflammation,cell apoptosis,and other factors.

Herbal medicineNetwork pharmacologyPostmenopausal osteoporosisPerimenopause

单珊、王佳晨、陈怡洁、徐哲昀、李伊伊、盛祝梅、黄飞翔、孟丽丽、张治芬

展开 >

310053 杭州,浙江中医药大学第四临床医学院妇产科

杭州市妇产科医院生殖内分泌科

杭州市妇产科医院中医科

杭州市妇产科医院药剂科

展开 >

中草药 网络药理学 绝经后骨质疏松症 围绝经期

浙江省中医药现代化专项

2021ZX013

2024

浙江医学
浙江省医学会

浙江医学

CSTPCD
影响因子:0.428
ISSN:1006-2785
年,卷(期):2024.46(7)
  • 14